Pluristem Therapeutics Inc (NASDAQ:PSTI)

0.5021
Delayed Data
As of Apr 18
 -0.0677 / -11.88%
Today’s Change
0.50
Today|||52-Week Range
1.52
-36.29%
Year-to-Date
No recent news for Pluristem Therapeutics Inc.

Today’s Trading

Previous close0.57
Today’s open0.56
Day’s range0.50 - 0.56
Volume1,757,957
Average volume (3 months)477,573
Market cap$91.6M
Data as of 4:00pm ET, 04/18/2019

Growth & Valuation

Earnings growth (last year)+21.88%
Earnings growth (this year)--
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales2,583.39
Price/Book2.51

Competitors

 Today’s
change
Today’s
% change
APTOAptose Biosciences I...-0.02-1.08%
ETTXEntasis Therapeutics...-0.86-13.52%
ARAVAravive Inc+0.23+3.83%
IGCIndia Globalization ...+0.05+2.98%
Data as of 8:00pm ET, 04/18/2019

Financials

Next reporting dateMay 8, 2019
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$50.0K
Annual profit (last year)-$26.1M
Net profit margin-52,252.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Co-Chief Executive Officer
Zami Aberman
President, Co-Chief Executive Officer &
Director
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts